FDA Eyes 18 Dairy Definitions, From Regulation to Retirement
Published Date: 7/17/2025
Proposed Rule
Summary
The FDA wants to get rid of 18 old rules that define what certain dairy products have to be. They believe these rules aren’t needed anymore and removing them will cut down on extra paperwork for dairy makers. If you have thoughts, speak up by September 15, 2025—after that, the door closes!
Analyzed Economic Effects
3 provisions identified: 3 benefits, 0 costs, 0 mixed.
Revocation of 18 dairy standards
The FDA is proposing to remove 18 standards of identity for dairy products. The agency says this would reduce redundant regulatory requirements and could create cost savings or negligible costs for small dairy businesses; comments are due by September 15, 2025, and the revocations would be effective 60 days after a final rule is published.
Niche dairy standards removed (13 products)
FDA tentatively concludes 13 dairy standards that cover foods with little to no U.S. market should be revoked, including acidified milk; acidified sour cream; caciocavallo siciliano cheese; low sodium cheddar and colby; cook cheese; gammelost; high-moisture jack; Nuworld; Samsoe; Sap sago; goat's milk ice cream; and mellorine. FDA says revoking these standards would affect few small businesses and may give any small firms that market these products more flexibility in product development.
Five redundant cheese standards targeted
FDA proposes to revoke five cheese standards it considers redundant—cold-pack cheese food with fruits/vegetables/meats; cream cheese with other foods; pasteurized blended cheese with fruits/vegetables/meats; pasteurized process cheese with fruits/vegetables/meats; and pasteurized process cheese food with fruits/vegetables/meats. FDA states revoking these redundant standards may reduce confusion and generate cost savings for manufacturers (NAICS 311513), many of which it estimates are small businesses.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-20848, Use of Salt Substitutes To Reduce the Sodium Content in Standardized Foods
The FDA is changing food rules to allow salt substitutes in many standardized foods, helping companies make lower-sodium options. This move aims to cut heart disease risks by reducing sodium without changing how foods basically taste or look. The new rule kicks in December 14, 2026, and food makers have until November 12, 2026, to raise any concerns, with no big costs expected.
2026-16296, Substances Generally Recognized as Safe
The Food and Drug Administration (FDA or we) is proposing to require the submission of generally recognized as safe (GRAS) notices for the use of a human or animal food substance purported to be GRAS under the conditions of its intended use under the Federal Food, Drug, and Cosmetic Act (FD&C Act).
2026-14073, Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments
The FDA wants to make it easier for drug makers who work in several locations to register as one company instead of many. They’re also updating rules for foreign drug companies to match new laws about handling health threats. If you’re in drug manufacturing, get ready to comment by September 11, 2026, and keep an eye on possible paperwork changes that could affect your business.
2026-13047, Establishment Registration and Product Listing for Tobacco Products
The FDA wants to make sure all tobacco product makers, both in the U.S. and abroad, register their businesses and list their products. This new rule closes a big gap by including foreign companies, helping the FDA keep better track of tobacco products for public health. Comments on this proposal are open until September 14, 2026, so affected businesses should get ready to update their info and possibly face new costs.
2025-04978, Nonprescription Drug Product With an Additional Condition for Nonprescription Use
The FDA is delaying a new rule about nonprescription drugs that have extra conditions for use. Originally set to start on March 21, 2025, the rule’s start date is now pushed back to May 27, 2025, to allow more time for review. This affects drug makers and consumers by giving everyone extra time to prepare for the new requirements without any immediate cost changes.
2025-01840, Nonprescription Drug Product With an Additional Condition for Nonprescription Use
The FDA’s new rule about nonprescription drugs needing extra conditions before use was set to start on January 27, 2025, but it’s now delayed until March 21, 2025. This delay follows a presidential order to pause and review new rules before they take effect. Drug makers, sellers, and consumers should note the new start date and get ready for the updated rules soon.
Previous / Next Documents
Previous: 2025-13423, Revocation of Food Standards for 11 Products Not Currently Sold
The FDA wants to get rid of food rules for 11 products that aren’t sold anymore in the U.S. This cleanup helps cut down on old, unnecessary regulations and makes things simpler for everyone. If you have thoughts, you’ve got until August 18, 2025, to speak up—no money changes, just less red tape!
Next: 2025-13463, Television Broadcasting Services Jacksonville, Oregon
The FCC wants to switch a new educational TV station in Jacksonville, Oregon, from channel 4 to channel 24. This change helps the station avoid reception problems and reach viewers better. People can share their thoughts by August 18, 2025, so the station can start broadcasting smoothly on the new channel.